Bevacizumab Injection 400mg/16ml Avevmy 400

A chemical called Bevacizumab Inject aids the body in the battle against cancer.It prevents specific types of blood vessels from developing into cancer cells. This aids in slowing the growth of malignant cells by denying the cancer cells the nutrients they need to develop

How it operates. Vascular endothelial growth factor is a protein that bevacizumab targets in cancer cells (VEGF). In order for malignancies to obtain food and oxygen from the blood, this protein aids in the growth of blood vessels. A blood supply is required for the survival and growth of all malignancies.

An antiangiogenic medication called Avastin (bevacizumab) is used to treat certain types of brain tumours as well as cancers of the breast, colon, rectum, kidney, and lung. Avastin is typically administered along with other cancer medications.

• Avastin 400 mg/16 ml Injection side effects may include weakness
• body aches
• perspiration
• fatigue
• nausea
• vomiting
• diarrhoea, and stomach pain.
• Consult your doctor if these adverse effects persist or worsen.

Epistaxis, headache, hypertension, rhinitis, proteinuria, taste alteration, dry skin, haemorrhage, lacrimation disorder, back pain, and exfoliative dermatitis were the most frequent adverse reactions seen in patients receiving Avastin alone or at a rate of >10% in combination with other anti-cancer treatments.

Chemotherapy targets rapidly proliferating cells, such as cancer cells. Chemotherapy functions differently than Avastin® (bevacizumab). Avastin utilises a distinct strategy to combat your cancer when paired with chemotherapy. Avastin is an anti-angiogenic (tumor-starving) treatment.

If you stop taking Avastin, you should wait six months before trying to get pregnant. preparing to get pregnant. A woman’s ability to become pregnant may be hampered if she takes Avastin since it may cause her ovaries to cease functioning.

Metastatic breast cancer, non-small-cell lung cancer, glioblastoma, renal cell carcinoma, ovarian cancer, and cervical cancer are now among its indications.It was initially approved for the treatment of metastatic colorectal cancer in conjunction with chemotherapy.

Bleeding (25%), hypertension (5%), problems with wound healing (4%), gastrointestinal perforation (2%), and arterial thromboembolism (1%), on average, were bevacizumab-related toxicities. The median OS was 13.1 months (95% CI 11.4-14.9) and the median progression-free survival was 7.5 months (95% CI 6.3-8.7).

Check this Anti Cancer Product Bevacizumab Injection 400mg Krabeva or you may explore more Anti Cancer Products by clicking here

We are an exporter from India and work in excess countries like the UAE , Oman, Qatar, Myanmar, Saudi Arabia, Netherland, Albania, Saint lucia , Jordan , Romania ,South africa , and so on.